Cell signals transduced by complement

被引:113
作者
Bohana-Kashtan, O
Ziporen, L
Donin, N
Kraus, S
Fishelson, Z [1 ]
机构
[1] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel
[2] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
基金
以色列科学基金会;
关键词
complement; signaling; apoptosis; inflammation; resistance; lymphocytes;
D O I
10.1016/j.molimm.2004.04.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The complement system is composed of soluble blood plasma proteins and cell membrane proteins. A major function of the soluble complement proteins is to bind to and destroy invading pathogens. The membrane proteins of the complement system are divided into complement receptors and complement regulatory proteins. Complement receptors on phagocytic cells promote binding and engulfment of pathogens coated with complement opsonins, whereas complement regulatory proteins protect healthy tissues from accidental damage by the soluble complement proteins. Upon binding of complement proteins or protein fragments that are generated during complement activation, these receptors and regulatory proteins transduce various signals into cells bearing them. The complement membrane attack complex C5b-9 binds to cell membranes, independent of any receptor, and also activates multiple signaling pathways. The receptor-dependent and -independent signals transduced by complement components are of great consequence to health and disease. Complement plays an important role in immunoregulation by activating B and T lymphocytes. It may also exert pro- or anti-apoptotic effects on various cell types. At sublytic doses, the complement membrane attack complex has wide-range effects on many cell types leading to cellular responses, such as secretion, adherence, aggregation, chemotaxis and even cell division. Sublytic complement also induces increased cell resistance to lytic doses of complement. Finally, certain pathogens take advantage of complement membrane proteins to gain entry into cells. The emerging data on these complement-related signaling pathways is hereby described. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:583 / 597
页数:15
相关论文
共 186 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]  
[Anonymous], 1998, HUMAN COMPLEMENT SYS
[3]   p38 Mitogen-activated protein kinase protects glomerular epithelial cells from complement-mediated cell injury [J].
Aoudjit, L ;
Stanciu, M ;
Li, HP ;
Lemay, S ;
Takano, T .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (04) :F765-F774
[4]   CD46, a new costimulatory molecule for T cells, that induces p120CBL and LAT phosphorylation [J].
Astier, A ;
Trescol-Biémont, MC ;
Azocar, O ;
Lamouille, B ;
Rabourdin-Combe, C .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6091-6095
[5]   RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase [J].
Badea, T ;
Niculescu, F ;
Soane, L ;
Fosbrink, M ;
Sorana, H ;
Rus, V ;
Shin, ML ;
Rus, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) :502-508
[6]  
BAGCHUS WM, 1986, LAB INVEST, V55, P680
[7]   Activation of Epstein-Barr virus/C3d receptor (gp140, CR2, CD21) on human cell surface triggers pp60src and Akt-GSK3 activities upstream and downstream to PI 3-kinase, respectively [J].
Barel, M ;
Balbo, M ;
Le Romancer, M ;
Frade, R .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (09) :2557-2566
[8]   Activation of the EBV/C3d receptor (CR2, CD21) on human B lymphocyte surface triggers tyrosine phosphorylation of the 95-kDa nucleolin and its interaction with phosphatidylinositol 3 kinase [J].
Barel, M ;
Le Romancer, M ;
Frade, R .
JOURNAL OF IMMUNOLOGY, 2001, 166 (05) :3167-3173
[10]  
BITTERSUERMANN D, 1990, CURR TOP MICROBIOL, V153, P222